Table 4.
Matrix of pairwise FST values of the STs in various European countries. Analyses were not conducted on countries associated with too few clinical strains (i.e. Denmark, Hungary, Italy, Finland, Switzerland and Poland)
| Germany | The Netherlands | France | Slovenia | Sweden | |
|---|---|---|---|---|---|
| FST (P-value) | FST (P-value) | FST (P-value) | FST (P-value) | FST (P-value) | |
| The Netherlands |
0.08975
(< 0.00001) |
– | – | – | – |
| France |
0.03957
(< 0.00001) |
0.02663 (0.00684) |
– | – | – |
| Slovenia |
0.04417
(< 0.00001) |
0.05631
(< 0.00001) |
0.01369 (0.06348) |
– | – |
| Sweden | 0.02722 (0.06934) |
0.02356 (0.11133) |
-0.00526 (0.56836) |
0.02075 (0.10840) |
– |
| Austria | 0.02527 (0.09766) |
0.07706
(< 0.00001) |
0.01494 (0.18555) |
-0.02581 (0.95801) |
0.02188 (0.17969) |
Values in bold type were significant at a significance threshold of α = 0.0033